JENKINS; Scott
Patent Applications and Registrations
Patent applications and USPTO patent grants for JENKINS; Scott.The latest application filed is for "nanoparticulate cinacalcet compositions".
Company Profile
0.8.55
Trademarks
- JENKINS; Scott - Downingtown PA
- Jenkins; Scott - Dowingtown PA
- Jenkins; Scott - Downington PA
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Nanoparticulate Cinacalcet Compositions App 20150216822 - NEVILLE; Deborah ; et al. | 2015-08-06 |
| Nanoparticulate cinacalcet compositions Grant 9,012,511 - Neville , et al. April 21, 2 | 2015-04-21 |
| Nanoparticulate carverdilol formulations Grant 8,367,112 - Liversidge , et al. February 5, 2 | 2013-02-05 |
| Nanoparticulate quinazoline derivative formulations Grant 8,309,133 - Liversidge , et al. November 13, 2 | 2012-11-13 |
| Nanoparticulate Bisphosphonate Compositions App 20120128780 - Liversidge; Gary G. ; et al. | 2012-05-24 |
| Novel mometasone compositions and methods of making and using the same App 20120121653 - Jenkins; Scott ; et al. | 2012-05-17 |
| Nanoparticulate bisphosphonate compositions Grant 8,158,153 - Liversidge , et al. April 17, 2 | 2012-04-17 |
| Nanoparticulate Stabilized Anti-hypertensive Compositions App 20120076863 - Jenkins; Scott ; et al. | 2012-03-29 |
| Compositions For Site-specific Delivery Of Imatinib And Methods Of Use App 20120003319 - Liversidge; Gary ; et al. | 2012-01-05 |
| Nanoparticulate Cinacalcet Compositions App 20110287065 - Neville; Deborah ; et al. | 2011-11-24 |
| Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof Grant 8,003,127 - Liversidge , et al. August 23, 2 | 2011-08-23 |
| Injectable Nanoparticulate Olanzapine Formulations App 20110195095 - Liversidge; Gary ; et al. | 2011-08-11 |
| Nanoparticulate Bicalutamide Formulations App 20110159054 - Jenkins; Scott ; et al. | 2011-06-30 |
| Injectable nanoparticulate olanzapine formulations Grant 7,910,577 - Liversidge , et al. March 22, 2 | 2011-03-22 |
| Nanoparticulate And Controlled Release Compositions Comprising Vitamin K2 App 20110064803 - Devane; John G. ; et al. | 2011-03-17 |
| Nanoparticulate azelnidipine formulations App 20100221327 - Jenkins; Scott ; et al. | 2010-09-02 |
| Modified Release Famciclovir Compositions App 20100136106 - Liversidge; Gary ; et al. | 2010-06-03 |
| Nanoparticulate stabilized anti-hypertensive compositions App 20100028439 - Jenkins; Scott ; et al. | 2010-02-04 |
| Combination Of A Triptan And An Nsaid App 20090311335 - JENKINS; Scott ; et al. | 2009-12-17 |
| Aerosol And Injectable Formulations Of Nanoparticulate Benzodiazepine App 20090304801 - Liversidge; Gary ; et al. | 2009-12-10 |
| Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor App 20090297596 - Devane; John ; et al. | 2009-12-03 |
| Modified Release Loxoprofen Compositions App 20090297602 - Devane; John G. ; et al. | 2009-12-03 |
| Modified Release Ticlopidine Compositions App 20090297597 - Liversidge; Gary ; et al. | 2009-12-03 |
| Nanoparticulate Bicalutamide Formulations App 20090291142 - JENKINS; Scott ; et al. | 2009-11-26 |
| Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin App 20090269400 - Devane; John ; et al. | 2009-10-29 |
| Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives App 20090252807 - Jenkins; Scott ; et al. | 2009-10-08 |
| Nanoparticulate Tacrolimus Formulations App 20090252806 - JENKINS; Scott ; et al. | 2009-10-08 |
| Nanoparticulate Anidulafungin Compositions and Methods for Making the Same App 20090238867 - Jenkins; Scott ; et al. | 2009-09-24 |
| Compositions For Site-specific Delivery Of Imatinib And Methods Of Use App 20090238884 - Liversidge; Gary ; et al. | 2009-09-24 |
| Dosing Regimen App 20090149479 - Jenkins; Scott ; et al. | 2009-06-11 |
| Nanoparticulate benzothiophene formulations App 20090035366 - Liversidge; Gary ; et al. | 2009-02-05 |
| Combination Of A Narcotic And Non-narcotic Analgesic App 20080226734 - Jenkins; Scott ; et al. | 2008-09-18 |
| Nanoparticulate Sorafenib Formulations App 20080213374 - Carty; Sarah ; et al. | 2008-09-04 |
| Nanoparticulate tacrolimus formulations App 20080152720 - Jenkins; Scott ; et al. | 2008-06-26 |
| Nanoparticulate posaconazole formulations App 20070281011 - Jenkins; Scott ; et al. | 2007-12-06 |
| Nanoparticulate carverdilol formulations App 20070202180 - Liversidge; Gary ; et al. | 2007-08-30 |
| Nanoparticulate aripiprazole formulations App 20070148100 - Jenkins; Scott | 2007-06-28 |
| Zonisamide And Nsaid Nanoparticulate Formulations App 20070134339 - Jenkins; Scott ; et al. | 2007-06-14 |
| Nanoparticulate tadalafil formulations App 20070104792 - Jenkins; Scott | 2007-05-10 |
| Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations App 20070065374 - Liversidge; Gary ; et al. | 2007-03-22 |
| Nanoparticulate ebastine formulations App 20070059371 - Liversidge; Gary G. ; et al. | 2007-03-15 |
| Nanoparticulate benidipine compositions App 20070042049 - Liversidge; Gary G. ; et al. | 2007-02-22 |
| Nanoparticulate clarithromycin formulations App 20070015719 - Jenkins; Scott ; et al. | 2007-01-18 |
| Nanoparticulate clopidogrel and aspirin combination formulations App 20070003615 - Jenkins; Scott ; et al. | 2007-01-04 |
| Nanoparticulate clopidogrel formulations App 20070003628 - Liversidge; Gary G. ; et al. | 2007-01-04 |
| Nanoparticulate acetaminophen formulations App 20060292214 - Jenkins; Scott ; et al. | 2006-12-28 |
| Nanoparticulate imatinib mesylate formulations App 20060275372 - Jenkins; Scott ; et al. | 2006-12-07 |
| Controlled release compositions comprising an acylanilide App 20060269596 - Liversidge; Gary ; et al. | 2006-11-30 |
| Nanoparticulate lipase inhibitor formulations App 20060246141 - Liversidge; Gary G. ; et al. | 2006-11-02 |
| Nanoparticulate quinazoline derivative formulations App 20060246142 - Liversidge; Gary G. ; et al. | 2006-11-02 |
| Nanoparticulate corticosteroid and antihistamine formulations App 20060216353 - Liversidge; Gary ; et al. | 2006-09-28 |
| Injectable compositions of nanoparticulate immunosuppressive compounds App 20060210638 - Liversidge; Gary G. ; et al. | 2006-09-21 |
| Nanoparticulate bisphosphonate compositions App 20060210639 - Liversidge; Gary G. ; et al. | 2006-09-21 |
| Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof App 20060204588 - Liversidge; Gary ; et al. | 2006-09-14 |
| Aerosol and injectable formulations of nanoparticulate benzodiazepine App 20060198896 - Liversidge; Gary ; et al. | 2006-09-07 |
| Nanoparticulate formulations of docetaxel and analogues thereof App 20060188566 - Liversidge; Gary ; et al. | 2006-08-24 |
| Nanoparticulate candesartan formulations App 20060165806 - Liversidge; Gary ; et al. | 2006-07-27 |
| Nanoparticulate bicalutamide formulations App 20060159767 - Jenkins; Scott ; et al. | 2006-07-20 |
| Nanoparticulate tacrolimus formulations App 20060159766 - Jenkins; Scott ; et al. | 2006-07-20 |
| Nanoparticulate benzothiophene formulations App 20060159628 - Liversidge; Gary ; et al. | 2006-07-20 |
| Injectable nanoparticulate olanzapine formulations App 20060154918 - Liversidge; Gary ; et al. | 2006-07-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 